NCT02606877 A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination Status COMPLETED Phase PHASE4
NCT02598193 Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE4
NCT02579603 Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF Status COMPLETED Phase PHASE4
NCT02525484 A Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT02496182 Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment Status UNKNOWN Phase PHASE2/PHASE3
NCT02408744 Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease Status COMPLETED Phase PHASE1/PHASE2
NCT02296281 Safety and Efficacy Study of Pirfenidone to Treat Grade 2 or Above Radiation-induced Lung Injury Status UNKNOWN Phase PHASE2
NCT02262299 European Trial of Pirfenidone in BOS, A European Multi-center Study Status COMPLETED Phase PHASE2/PHASE3
NCT02141087 Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone Status APPROVED_FOR_MARKETING Phase N/A
NCT02136992 Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT01933334 Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) Status COMPLETED Phase PHASE2
NCT01872689 A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT01504334 Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF) Status UNKNOWN Phase PHASE2
NCT01366209 Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE3
NCT00754780 Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1 Status COMPLETED Phase PHASE2
NCT00662038 Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE3
NCT00332033 Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) Status COMPLETED Phase PHASE2
NCT00287729 Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE3